Epidemiological Study of Pandemic COVID-19 and Its Association with Some Chronic Disease in Sulaimani City, Kurdistan Region of Iraq

Abstract = 187 times | PDF = 114 times

Main Article Content

Shaxawan Azeez Maulood Muhammed Babakir Mina Salar Ibrahim Ali

Abstract

The study aims to provide the epidemiological characteristics of the COVID-19 patients who admitted to Shahid Dr Hemin Teaching Hospital in Sulaimani city, Iraq. It is a cross-sectional study, the data were collected by a convenience sampling method in the hospital, which started from 2nd October to 31th of December 2020. The current study included all the patients who admitted to the hospital, which involved 371 patients. The data were collected from patient’s medical record and a direct interview method was used for filling in the questionnaire form. The collected data were analysed by the SPSS program to produce descriptive statistics such as frequency, percentage, mean and standard deviation while Chi-square test used to find out the association between variables with considering a p-value ≤ 0.05 as a significant interpretation. The results show that the age of hospitalized COVID-19 patients ranges from 19-95 years old with mean of (63.69±12.73). The age of majority of patients 159 (42.9%) was between 65-79 years old followed by 50-64 years old 124 (33.4%). Male to female ratio was 2:1. Most of the patients were retired 119 (32.1%) in comparison to other occupations and illiterate patients 151(40.7%) were dominance over other patient’s education levels. In addition, majority of patients had hypertension 278(74.9%), diabetes 132 (35.6%) and cardiovascular disease (CVD) 130 (35.0%) and 230 (62.0%) and 141(38.0%) of them were in severe and moderate stage of disease respectively. Also, there was a significant association between the patient’s age group and patients’ outcome while for gender, occupation, and education level, stage of the disease, there were non-significant. The presence of CVD, hypertension and diabetes increase the mortality rate among the patients. In conclusion, age of COVID-19 patient has a great impact on increasing mortality rate and the presence of comorbidities among the patients significantly raise the mortality rate of COVID-19.

Keywords

Epidemiology, Risk factor, Demographic properties, COVID-19, Sulaimani city/ Iraq.

Downloads

Download data is not yet available.

Article Details

References

[1] C. Huang, Y. Wang, X. Li, L. Ren, L. J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, X, “Clinical features of patients infected with 2019 novel coronavirus in Wuhan,” China. Lancet 2020, 395, 497–506.
[2] World Health Organization. “Rolling updates on coronavirus disease (COVID-19),” 2020. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen (accessed on 29 September 2020).
[3] E. Stoye, “The pandemic in pictures: How coronavirus is changing the world,” Nature 2020. Available online: https://pubmed.ncbi.nlm.nih.gov/32265538/ (accessed on 29 September 2020).
[4] World Health Organization. “WHO Coronavirus Disease (COVID-19) Dashboard”. Available online: https: //covid19.who.int/ (accessed on 29 September 2020).
[5] E. Williamson, A. Walker, K. Bhaskaran, S. Bacon, C. Bates, C. Morton, “Factors associated with COVID-19-related death using OpenSAFELY,” Nature. 2020;584(7821):430-6.
[6] G. Anderson, J. Frank, C. Naylor, W. Wodchis, P. Feng, “Using socioeconomics to counter health disparities arising from the covid-19 pandemic,” BMJ. 2020;369.
[7] J. Ioannidis, “Global perspective of COVID-19 epidemiology for a full-cycle pandemic,” European journal of clinical investigation. 2020;50(12):e13423.
[8] S. Boccia, W. Ricciardi, J. Ioannidis, “What other countries can learn from Italy during the COVID-19 pandemic,” JAMA Intern Med. 2020; 180 (7): 927–8. 2020.
[9] M. Al-Hanawi, M. Mwale, N. Alshareef, A. Qattan, K. Angawi, R. Almubark, “Psychological Distress Amongst Health Workers and the General Public During the COVID-19 Pandemic in Saudi Arabia,” Risk management and healthcare policy. 2020;13:733-42.
[10] K. Liu, Y. Chen, R. Lin, K. Han, “Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients,” The Journal of infection. 2020;80(6):e14-e8.
[11] J. Ioannidis, C. Axfors, Contopoulos-Ioannidis, “Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters,” Environmental research. 2020;188:109890
[12] L. Ren, Y. Wang, Z. Wu, Z. Xiang, L. Guo, T. Xu, “Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study,” Chinese medical journal. 2020.
[13] F. Martos-Benítez, C. Soler-Morejón, D. García-del Barco, “Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico,” Internal and emergency medicine. 2021:1-11.
[14] G. Bwire, “Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?” SN Comprehensive Clinical Medicine. 2020;2(7):874-6.
[15] X. Yang, Y, Yu, J. Xu, H. Shu, J. Xia, H. Liu, “Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study,” The Lancet Respiratory medicine. 2020;8(5):475-81
[16] M. Arentz, E. Yim, Klaff L, S. Lokhandwala, F. Riedo, M. Chong, “Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State,” Jama. 2020;323(16):1612-4.
[17] L. Li, T. Huang, Y. Wang, Z. Wang, Y. Liang, T. Huang, “COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis,” Journal of medical virology. 2020;92(6):577-83.
[18] N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study,” The lancet. 2020;395(10223):507-13.
[19] D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, “Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China,” JAMA. 2020;323(11):1061-9.
[20] S. Boccia, W. Ricciardi, J. Ioannidis, “What other countries can learn from Italy during the COVID-19 pandemic,” JAMA Intern Med. 2020; 180 (7): 927–8. 2020.
[21] B. Saeed, R. Al-Shahrabi, O. Bolarinwa, “Socio-demographic correlate of knowledge and practice toward COVID-19 among people living in Mosul-Iraq: A cross-sectional study,” PloS one. 2021;16(3):e0249310.
[22] S. Drefahl, M. Wallace, E. Mussino, S. Aradhya, M. Kolk, M. Brandén, “A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden,” Nature communications. 2020;11(1):5097.
[23] R. Laxminarayan, B. Wahl, S. Dudala, K. Gopal, S. Neelima, K. Reddy, “Epidemiology and transmission dynamics of COVID-19 in two Indian states,” Science. 2020;370(6517):691-7.
[24] M. Mohanan, A. Malani, K. Krishnan, A. Acharya, “Prevalence of COVID-19 In Rural Versus Urban Areas in a Low-Income Country: Findings from a State-Wide Study in Karnataka,” India 2020.
[25] S. Shi, M. Qin, B. Shen, Y. Cai, T. Liu, F. Yang, “Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China,” JAMA cardiology. 2020;5(7):802-10.
[26] F. Martos-Benítez, C. Soler-Morejón, D. García-del Barco, “Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico,” Internal and emergency medicine. 2021:1-11.